A COMPREHENSIVE REVIEW ON RISK FACTORS AND DIETARY NUTRITIONALMANAGEMENT IN NEPHROLITHIASIS
Abstract
Kidneys are essential for life. They are major organs of excretory organs of the urinary system of the human body. All the metabolic activities of the body result in the formation of waste products and these are excreted mostly through the kidneys. Kidney stones have been associated with an increase to leads kidney failure. In a lifetime there is a chance of formation of kidney stones depending on diet and nutritional and environmental factors it may be considered as a very painful urological disorder. The kidney stone is hard deposits of acid salts and minerals developed from crystals buildup the inner surface of the kidneys. In our study, we assessed biochemical parameters efficiencies related to formation of different types of kidney stones. Nutrition plays a pivotal aspect in nephrolithiasis patients; organic and mineral analyses are carried out through the serum and plasma. It may also carry out that physiological dietary nutritional factors and daily routine habits that favor the formation of kidney stone disease. This research carried out to assess the relation between some biochemical assays and the recurring of stone formation. In which the patients were suffering from painful urination and back pain in the lower of abdomen. Under certain conditions, these stones obstruct the renal pelvis make intermittent pain. Prevention of these kidney stones requires behavioral lifestyle habits and nutritional interventions. This review represents a comprehensive study of renal stone formation and the nutritional dietary factor’s role in nephrolithiasis will certainly be helpful in decrease stone formation.
References
Machoy P Analytical evaluation of urinary calculi mineral composition in Annales Academiae Medicae Stetinesis 1995 January 1(vol 4, pp 259-271).
Chauhan C.K, Joshi, M.J, Vaidya AD Growth inhibition of struvite crystals in the Prescence of herbal extract Commiphora wightii Journal of Material in Medicine. 2009 Dec, 20 (1): 85- 92.
Sofia NH, Walter, TM, and Sanatorium T. Prevalence and risk factors of kidney stone. Global Journal for Research Analysis 2016 Mar, 5(3):183-7.
He JY, Deng SP, Ouyang JM. Morphology, particle size distribution, aggregation, and crystal phase of nanocrystal ties in the urine of healthy persons and lithogenic patients. IEEE Trans Nanobioscience.2010 june,9(2):156-63.
Moe, O.W, Kidney stones: pathophysiology and medical management. The lancet. 2006 January 28;367(9507):333-44.
Parks JH, Coward M, Coe FL. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney international. 1997 march 1;51(3):894- 900.
Odvina CV, Sakhaee k, Heller HJ, Peterson RD, Poindexter JR, Padalino PK, Pak CY. Biochemistry characterization of primary hyperparathyroidism with and without kidney stones. Urological research. 2007 june;35(3): 123 – 8.
Litwin MS, Saigal CS. Urololgic Disease in America. NIH publication 12 – 7865.
Taylor EN, Curhan GC. Fructose consumption and the risk of kidney stones. Kidney international. 2008 January 2; 73(2):207- 12.
Curhan GC, Willett WC, Speizer FE, Spiegelman D, stampfer Mj. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women Annals of internal medicine. 1997 April 1; 126(7) 497 -504.
Stamatiou KN, Karanasiou IV, Lacroix RE, Kavouras NG, Papadimitriou VT, chlopsios C, Lebren FA, Sofras F. prevalence of urolithiasis in rural thebes, Greece Rural and remote health. 2006 December 1;6(4):1-8.
Reddy ST, Wang Cy, Sakhaee K, Brinkely L, Pak CY. Effect of low – carbohydrate high protein diets on acid – base balance, stone – forming propensity, and calcium metabolism. AM J Kidney disease.2022 August;40(2):265 – 74.
Ambuhl PM. Protein intake in renal and hepatic disease. Int J Vitam Nutr Res.2011 March;81 (2-3):162 – 72.
Richter M, Baerlocher K, Bauer JM, Elamadfa I, Heseker H, Leschik – Bonnet E, Stangl G, Volkert D, Stehle p; on behalf of the German Nutritional Society (DGE) Revised Reference values for the intake of protein. Ann Nutr Metab.2019;74(3):242 – 250.
Reddy ST, Wang Cy, Sakhaee K, Brinkely L, Pak CY. Effect of low – carbohydrate high protein diets on acid – base balance, stone – forming propensity, and calcium metabolism. AM J Kidney disease.2022 August;40(2):265 – 74.
He Y, Chen X, Yu Z. The change of human NA+/dicarboxylate co – transporter 1 expression in the kidney and its relationship with pathogenesis of nephrolithiasis. Zhonghua yi xue za zhi. 2001 sepetmber 1;81(17):1006 – 9.
Seiner R, Seidler A, Voss S, Hesse A. The oxalate content of fruit and vegetable juices, nectars and drinks. Journal of food Composition and Analysis. 2016 February 1; 45:108 – 12.
Holmes RP, Goodman HO, Assimos DG. Contribute of dietary oxalate to urinary oxalate excretion. Kidney international.2001 January 1;59(1):270 – 6.
Nishiura JL, Martini LA, Mendonca CO, Schor N, Heilberg IP Effect of calcium intake on urinary oxalate excretion in calcium stone – forming patients Brazilian journal of medicine and biological research 2002 june;35(6):669 – 75.
Pak CY, Adams – Huet B, Poindexter JR, Pearle MS, Peterson RD, Moe OW. Relative effect of urinary calcium and oxalate on saturation of calcium and oxalate on saturation of calcium oxalate Rapid Communication. Kidney international. 2004 November 1;66(5):2032 – 7.
Silver J, Friedlaender MM, Rubinger D, Popovtzer MM. sodium – dependent idiopathic hypercalciuria in renal stone formers. The Lancet.1983 August 27;322(8348)):484 – 6.
Sabot J, Powerll MJ, Breidan MJ, Gurr FW. Influence of urinary sodium on calcium excretion in normal individuals: A redefinition of hypercalciuria Medical Journal of Australia 1984 March; 140(6): 354- 6.
Nishiura JL, Martini LA, Mendonca CO, Schor N, Heliberg IP Effect of calcium intake on urinary oxalate excretion in calcium stone – forming patients. Brazilian journal of Medical and Biological research.2002 june;35(6):669 – 75.
Kosambi DD. The culture and civilisation of ancient India in historical outline. London, UK: Routledge and K Paul;1965.
Sorensen MD. Calcium intake and urinary stone disease. Translational andrology and urology.2014 September;3(3):235.
Lin BB, Lin ME, Huang RH, Hong YK, Lin BL, He XJ. Dietary and life style factors for primary preventation of nephrolithiasis: a systematic review and meta – analysis. BMC nephrology.2020 December ;21(1): 1 – 3.
Yoon V, Adams – Huet B, Sakhaee K, Maalouf NM. Hyperinsulinemia and urinary calcium excretion in calcium stone formers with idiopathic hypercalcuria. The Journal of Clinical Endocrinology & Metabolism 2013 June 1;98(6):2589 – 94
Rodgers AL, Siener R. The efficiency of Polyunsaturated fatty acids as protectors against calcium oxalate renal stone formation: a review Nutrients: 2020April; 12(4):1069
Barghouthy Y, Corrales M, Doizi S, Somani BK, Traxer O. Tea and coffee consumption and pathophysiology related to kidney stone formation.: A systemic review. World Journal of Urology. 2021 July;39(7):2417 – 26.
Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med.1992 October 15;327(16):141 – 52.
Bensatal A, Quahrani MR. Inhibition of crystallization of calcium oxalate by the extraction of calcium oxalate by the extraction of Tamarix gallica L. Urol Res.2008 Dec;36(6):283 – 7.
Balaji KC, Menon M. Mechanism of stone formation. Urol Clin of North America. 1997; 24(1): 1-11.
Beningo V, Canonica CS, Bettinelli A, Von Viger RO, Truttmann AC, Bianchetti MG. Hypomagnesaemia – hypercalcuria – Nephrocalcinosis: A report of nine cases and a review. Nephrology Dialysis Transplantation. 2000 May 1; 15(5):605 – 10.
Rumsby, G, 2000. Rumsby G. Molecular basis of primary hyperoxaluria and strategies for diagnosis. Expert Opinion on Orphan Drugs. 2015 Jun 3;3(6):663-73.
Bichler KH, Eipper E, Naber K, Barun V, Zimmermann R, Lahme S. Urinary infection stones. International journal of antimicrobial agents.2002 June 1;19(6):488 – 98.
Barbas C, Garcia A, Saavedra L, Muros M. Urinary analysis of nephrolithiasis markers. J Chromatography B Analyte Techno Biomed Life Science 2002 December 5;781(1 – 2):433 – 55.
Ettinger B, Citron JT, Livermore B, Dolman LI. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. The Journal of urology. 1988 Apr 1;139(4):679-84.
Brocks P, Dahl C, Wolf H, Transbøl IB. Do thiazides prevent recurrent idiopathic renal calcium stones?. The Lancet. 1981 Jul 18;318(8238):124-5.
Lingeman JE, Siegel YI, Steele B, Nyhuis AW, Woods JR. Management of lower pole nephrolithiasis: a critical analysis. J Urol. 1994; 151(3): 663-667.
Mortensen JT, Schultz A, Ostergaard AH. Thiazides in the prophylactic treatment of recurrent idiopathic kidney stones. Int Urol Nephrol. 1986;18(3):265–669.
Khan F, Haider MF, Singh MK, Sharma P, Kumar T, Neda EN. A comprehensive review on kidney stones, its diagnosis and treatment with allopathic and ayurvedic medicines. Urol Nephrol Open Access J. 2019;7(4):69-74.
Çakici ÖU, Ener K, Keske M, Altinova S, Canda AE, Aldemir M, Ardicoglu A. Open stone surgery: a still-in-use approach for complex stone burden. Central European Journal of Urology. 2017 Jun 6;70(2):179.
Micali S, Grande M, Sighinolfi MC, et al. Reviews in endourology: medical therapy of urolithiasis. Journal of Endourology. 2006;20(11):841–847.
Romics I. The role of alpha–adrenoreceptors in the treatment of urological diseases. Neurochem Int. 2007;51(5):328–331.
Grosser T, Smyth E, FitzGerald GA. Anti‒inflammatory, antipyretic and analgesic agents; pharmacotherapy of gout. In: Brunton LL, editor. Goodman and Gilman’s the pharmacological basis of therapeutics. 12th ed. New York: McGraw Hill; 2011. p. 959–1004.
Finkielstein VA, Goldfarb DS. Strategies for preventing calcium oxalate stones. CMAJ. 2006;174(10):1407–1409.
Reynolds TM. Chemical pathology clinical investigation and management of nephrolithiasis. J Clin Pathol. 2005; 58:134–140.
Saklayen MG. Medical management of nephrolithiasis. Med Clin North Am. 1997;81(3):785–799
Spernat D, Kourambas J. Urolithiasis– medical therapies. BJU Int. 2011;108(Suppl 2):9–13.
Bandi G, Nakada SY, Penniston KL. Practical approach to metabolic evaluation and treatment of the recurrent stone patient. WMJ. 2008;107(2):91–100.
Heilberg IP, SchorN. Renal stone disease: causes, evaluation and medical treatment. Arq Bras Endocrinol Metabol. 2006;50(4):823–831
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Shaik Basha, Ivvala Anand Shaker, Inampudi Sailaja
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The contents of PUJHSR are protected under Indian and international copyrights. However, the journal contents are free for non-commercial purpose under the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported License (https://creativecommons.org/licenses/by-nc-sa/4.0/).
